{
  "retracted": false,
  "timestamp": 1592265600000,
  "updates": [
    {
      "timestamp": 1592296890241,
      "identifier": {
        "doi": "10.1007/s10557-020-07023-8"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10557-019-06919-4"
  },
  "journal": "Cardiovascular Drugs and Therapy",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)"
}
